⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

TransCode Therapeutics, Inc. Common Stock

$1.69
-0.03 (-1.74%)

Market Capitalization:

$28.61M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

TransCode Therapeutics Market Segments

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$1.69
Close$1.69
Low$1.69
Low Change0.00 (0.00%)
High$1.69
High Change+0.00 (+0.00%)
Range$0.00
Volume213
Dollar Volume$359.97

Regular Trading Hours Yesterday

+0.04(+2.38%)
Open$1.68
Close$1.72
Low$1.63
Low Change-0.05 (-3.18%)
High$1.74
High Change+0.06 (+3.57%)
Range$0.11
Volume7.846K
Dollar Volume$13.50K

Premarket Yesterday

*No Trades in Segment

TransCode Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

TransCode Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.84
10 Day Moving Average (SMA10)$1.96
20 Day Moving Average (SMA20)$2.44
50 Day Moving Average (SMA50)$4.84
100 Day Moving Average (SMA100)$5.62
200 Day Moving Average (SMA200)$7.32

TransCode Therapeutics Statistics

Average Volume (30 Days)65.17K
P/E Ratio (Current)-.04
EPS (Current)-$43.73
Dividend Yield0.00%
Free Cash Flow-$22.61M
Cash Ratio1.55
Current Ratio1.97
Quick Ratio1.97
Debt to Equity-0.02
Enterprise Value-$5.94M
EV to EBITDA0.16
EV to Sales
Price to Book-0.06
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.31%
Return on Equity1.67%

TransCode Therapeutics Stock Splits

There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.

DateTypeRatio
May 15, 2025Reverse28:1
Dec 4, 2024Reverse33:1
Jan 16, 2024Reverse40:1
May 23, 2023Reverse20:1

TransCode Therapeutics Dividends

There have been no dividends for TransCode Therapeutics (RNAZ).